Completely agree!! The register should be much tighter as well, and with clinical trials progressing to the final stages we are in a very exciting time for the company and shareholders. 2024 is poised to be a big year!
Cheers
EMvision Research Notes, page-2227
-
- There are more pages in this discussion • 336 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.16 |
Change
-0.130(5.68%) |
Mkt cap ! $184.5M | |||
| Open | High | Low | Value | Volume |
| $2.28 | $2.29 | $2.15 | $73.74K | 33.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1449 | $2.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.30 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| EMV (ASX) Chart |